Production Linked Incentive (PLI) Scheme

The Production Linked Incentive (PLI) Scheme is a flagship industrial-policy instrument introduced by the Government of India to convert the country into a global manufacturing hub and reduce import dependence, particularly on China. It was first announced for mobile-phone and electronics manufacturing in March 2020 (notified by the Ministry of Electronics and Information Technology in April 2020) and was then progressively extended through the Union Budget 2021-22, which earmarked roughly ₹1.97 lakh crore (about US$26 billion) across an expanding list of sectors over five years. The scheme draws its administrative authority from the executive powers of line ministries—principally the Department for Promotion of Industry and Internal Trade (DPIIT) under the Ministry of Commerce and Industry, MeitY, the Ministry of Pharmaceuticals, and others—each of which issues sector-specific guidelines and budgetary sanctions. It forms a central plank of the Atmanirbhar Bharat (self-reliant India) initiative and the broader "Make in India" framework.

Procedurally, the PLI mechanism rests on a single defining principle: incentives are disbursed only against incremental sales of eligible products manufactured in India, measured over a fixed base year. An applicant firm is selected through a competitive application process administered by the relevant nodal ministry or a designated Project Management Agency. Selected firms commit to threshold investments and, in most sectors, to minimum incremental production or sales targets. In each performance year the firm files claims documenting its qualifying incremental sales above the base; an independent agency verifies the figures; and a cash incentive—commonly in the range of 4 to 6 per cent of incremental sales for electronics, with sector-specific rates and tapering schedules—is credited directly to the firm. The cycle repeats annually for the scheme's tenure, usually five years.

The mechanics vary materially by sector, reflecting differing industrial structures. For pharmaceuticals and bulk drugs, incentives are tied to manufacturing of specified Key Starting Materials, Drug Intermediates and Active Pharmaceutical Ingredients to break import reliance. For automobiles and auto components, the scheme rewards advanced automotive technology products and electric-vehicle components rather than legacy internal-combustion parts. The semiconductor and display programme operates on a fiscal-support model with capital subsidy of up to 50 per cent of project cost, a structural departure from the pure sales-linked formula. Solar PV modules, advanced chemistry cell batteries, specialty steel, telecom and networking products, white goods, food processing, textiles and drones each carry bespoke eligibility ceilings, investment floors and incentive slabs negotiated with industry.

Named beneficiaries illustrate the scheme's reach. Under the large-scale electronics PLI, contract manufacturers Foxconn, Wistron (whose Indian operations were acquired by the Tata Group in 2023-24) and Pegatron expanded iPhone assembly, and Apple's India exports crossed significant milestones by FY2024. Samsung and domestic champions Dixon Technologies and Lava also drew approvals from MeitY in New Delhi. In semiconductors, the Union Cabinet in 2024 cleared multiple fabrication and assembly proposals, including a Tata Electronics–Powerchip Semiconductor Manufacturing Corporation fab in Dholera, Gujarat. Micron Technology broke ground on an assembly and test facility near Sanand, Gujarat, in 2023. The Ministry of Pharmaceuticals reported new domestic API capacity for molecules previously sourced almost entirely from abroad.

The PLI Scheme is distinct from several adjacent instruments with which it is frequently conflated. Unlike a capital subsidy or the older Modified Special Incentive Package Scheme (M-SIPS), PLI does not reimburse a share of fixed-asset investment upfront; payment is contingent on demonstrated output and sales, transferring performance risk to the firm. It differs from an export subsidy such as the discontinued Merchandise Exports from India Scheme (MEIS), which the WTO panel in 2019 found inconsistent with the Agreement on Subsidies and Countervailing Measures—PLI rewards production regardless of destination and is structured to avoid that export-contingency objection. It is also broader than a tariff-based protection measure like the Phased Manufacturing Programme, which raises import duties to force localisation; PLI offers a positive fiscal pull rather than a punitive import push.

Controversies and edge cases have accompanied implementation. Uptake has been uneven: sectors such as advanced chemistry cell batteries and textiles saw slower-than-anticipated disbursement, prompting parliamentary committee scrutiny and reports of the government weighing the scheme's continuation or recalibration in 2025. Critics note that headline incentive figures vastly exceed actual disbursals, that the electronics gains rest heavily on assembly with limited deep value-addition, and that import of components may rise even as finished-goods exports grow. WTO compatibility concerns persist regarding any de facto local-content conditions. Conversely, the semiconductor outlay was substantially enlarged in 2021 to ₹76,000 crore, signalling political commitment to capital-intensive strategic sectors despite fiscal cost.

For the working practitioner, the PLI Scheme is the single most important lens through which to read India's contemporary industrial and trade strategy. Desk officers tracking supply-chain "de-risking" and "friend-shoring" should understand that India positions PLI as its principal answer to the China-plus-one realignment. Diplomats negotiating bilateral investment and free-trade agreements must reckon with PLI's interaction with subsidy disciplines and rules of origin. Analysts assessing India's macroeconomic trajectory, its current-account composition in electronics and pharmaceuticals, and its bid for semiconductor sovereignty will find that scheme-level data—approvals, committed investment, actual disbursal and incremental exports—are the operative indicators, more revealing than aggregate "Make in India" rhetoric.